Evaluation of Efficacy of Acarbose on Glucose Fluctuation and Postprandial Glucose Using Continuous Glucose Monitoring in Type 2 Diabetes Mellitus
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The objective of this study was to evaluate the effects of the α-glucosidase inhibitor acarbose on glucose fluctuations in patients with type 2 diabetes using continuous glucose monitoring (CGM). METHODS: CGM was performed for 4 days (72 h), and acarbose at 300 mg/day was administered on two of these days but not on the other two days. The effects on blood glucose fluctuations were evaluated. RESULTS: We recruited a total of 10 patients (five men and five women) with a mean ± SD age of 63.1 ± 12.1 years, body mass index of 22.6 ± 5.4 kg/m(2), and glycohemoglobin of 9.9 ± 1.9%. During treatment with acarbose, significant decreases in median (range) SD of 24-h mean blood glucose (22.48 [6.39-47.22] mg/dL vs. 32.78 [18.83-58.93] mg/dL, P = 0.004), 24-h blood glucose fluctuations (453.27 [128.51-903.94] mg·h/dL vs. 677.05 [358.03-1,234.57] mg·h/dL, P = 0.002), and mean amplitude of glycemic excursions (65.00 [18.17-117.50] vs. 97.09 [53.00-166.67], P = 0.010) occurred compared with no treatment. CONCLUSIONS: Acarbose reduced excessive blood glucose fluctuations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Translating the A1C assay into estimated average glucose values
Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & for the A1c-Derived Average Glucose (ADAG) Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0545 · Cited by 1,812 · cited 1×
“However, it has been noted that HbA 1C is an indicator of mean blood glucose over a long period, 4 and it does not necessarily reflect detailed daily blood glucose fluctuations.”
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Glucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371 · cited 1×
“6,7 Data also suggest that PPG is a stronger predictor of microvascular complications.”
Insulin glargine or NPH combined with metformin in type 2 diabetes: The LANMET study
Yki-Järvinen, H., Kauppinen-Mäkelin, R., Tiikkainen, M., Vähätalo, M., Virtamo, H., Nikkilä, K., Tulokas, T., Hulme, S., Hardy, K., McNulty, S., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0132-0 · Cited by 434 · cited 1×
“18,19 In recent years, the importance of treatment targeting postprandial blood glucose has become clear, and in 2008 the International Diabetes Federation published ‘‘Guideline for Management of Postmeal Glucose.’’”
Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes
Woerle, H. J., Neumann, C., Zschau, S., Tenner, S., Irsigler, A., Schirra, J., Gerich, J. E., & Göke, B. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.11.011 · Cited by 316
Cited by
Derosa, G., & Maffioli, P. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.31621 · Cited by 434
“[30] conducted a study using continuous glucose monitoring (CGM) to assess mean amplitude of glycemic excursions (MAGE) with acarbose.”
MethodImai, S., Fukui, M., & Kajiyama, S. (2014) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.13-67 · Cited by 81
Derosa, G., & Maffioli, P. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.04.012 · Cited by 76
Kasthuri, S., Poongothai, S., Anjana, R. M., Selvakumar, J., Muthukumar, S., Kayalvizhi, S., Tariq, S., Honey, E., Gupta, P. K., Venkatesan, U., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0484 · Cited by 13
Metadata
- Authors
- Mori, Y., Shiozaki, M., Matsuura, K., Tanaka, T., Yokoyama, J., & Utsunomiya, K.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2011-04
- Volume
- 13
- Issue
- 4
- Pages
- 467-470
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2071166447
- Cited by
- 15
- References
- 5
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of Efficacy of Acarbose on Glucose Fluctuation and Postprandial Glucose Using Continuous Glucose Monitoring in Type 2 Diabetes Mellitus. https://app.cochat.ai/papers/10.1089/dia.2010.0153
- The paper
- Mori, Y., Shiozaki, M., Matsuura, K., Tanaka, T., Yokoyama, J., & Utsunomiya, K. (2011). Evaluation of Efficacy of Acarbose on Glucose Fluctuation and Postprandial Glucose Using Continuous Glucose Monitoring in Type 2 Diabetes Mellitus. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2010.0153
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.